vs
Side-by-side financial comparison of FONAR CORP (FONR) and LCNB CORP (LCNB). Click either name above to swap in a different company.
FONAR CORP is the larger business by last-quarter revenue ($25.5M vs $23.9M, roughly 1.1× LCNB CORP). LCNB CORP runs the higher net margin — 23.7% vs 8.0%, a 15.7% gap on every dollar of revenue. On growth, LCNB CORP posted the faster year-over-year revenue change (5.1% vs 2.4%). LCNB CORP produced more free cash flow last quarter ($33.4M vs $-227.0K). Over the past eight quarters, LCNB CORP's revenue compounded faster (15.7% CAGR vs -0.3%).
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
LCNB Corp is a United States-based financial holding company that operates through its national bank subsidiary, providing a full suite of retail and commercial banking products and services including deposit accounts, various loan products, wealth management, and insurance solutions primarily to individual consumers, small and medium-sized enterprises and local community organizations across regional markets in Ohio.
FONR vs LCNB — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.5M | $23.9M |
| Net Profit | $2.1M | $5.7M |
| Gross Margin | — | — |
| Operating Margin | 13.5% | 29.2% |
| Net Margin | 8.0% | 23.7% |
| Revenue YoY | 2.4% | 5.1% |
| Net Profit YoY | 4.7% | -7.6% |
| EPS (diluted) | — | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.5M | $23.9M | ||
| Q3 25 | $26.0M | $23.8M | ||
| Q2 25 | $27.3M | $22.8M | ||
| Q1 25 | $27.2M | $21.5M | ||
| Q4 24 | $24.9M | $22.7M | ||
| Q3 24 | $25.0M | $21.4M | ||
| Q2 24 | $25.9M | $19.3M | ||
| Q1 24 | $25.7M | $17.8M |
| Q4 25 | $2.1M | $5.7M | ||
| Q3 25 | $2.3M | $6.9M | ||
| Q2 25 | $729.3K | $5.9M | ||
| Q1 25 | $2.5M | $4.6M | ||
| Q4 24 | $2.0M | $6.1M | ||
| Q3 24 | $3.1M | $4.5M | ||
| Q2 24 | $830.4K | $925.0K | ||
| Q1 24 | $1.9M | $1.9M |
| Q4 25 | 13.5% | 29.2% | ||
| Q3 25 | 14.1% | 35.6% | ||
| Q2 25 | 5.3% | 31.6% | ||
| Q1 25 | 15.2% | 25.6% | ||
| Q4 24 | 11.9% | 32.9% | ||
| Q3 24 | 21.0% | 24.9% | ||
| Q2 24 | 7.4% | 4.9% | ||
| Q1 24 | 16.8% | 12.5% |
| Q4 25 | 8.0% | 23.7% | ||
| Q3 25 | 8.7% | 29.1% | ||
| Q2 25 | 2.7% | 26.0% | ||
| Q1 25 | 9.2% | 21.4% | ||
| Q4 24 | 7.9% | 27.0% | ||
| Q3 24 | 12.6% | 21.2% | ||
| Q2 24 | 3.2% | 4.8% | ||
| Q1 24 | 7.3% | 10.7% |
| Q4 25 | — | $0.40 | ||
| Q3 25 | — | $0.49 | ||
| Q2 25 | — | $0.41 | ||
| Q1 25 | — | $0.33 | ||
| Q4 24 | — | $0.44 | ||
| Q3 24 | — | $0.31 | ||
| Q2 24 | — | $0.07 | ||
| Q1 24 | — | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $121.0K | $21.6M |
| Total DebtLower is stronger | — | $104.4M |
| Stockholders' EquityBook value | $176.9M | $273.9M |
| Total Assets | $217.2M | $2.2B |
| Debt / EquityLower = less leverage | — | 0.38× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $121.0K | $21.6M | ||
| Q3 25 | $122.0K | $35.9M | ||
| Q2 25 | $56.5M | $49.8M | ||
| Q1 25 | $123.0K | $37.7M | ||
| Q4 24 | $121.0K | $35.7M | ||
| Q3 24 | $136.0K | $39.4M | ||
| Q2 24 | $56.5M | $34.9M | ||
| Q1 24 | $134.0K | $33.0M |
| Q4 25 | — | $104.4M | ||
| Q3 25 | — | $104.7M | ||
| Q2 25 | — | $105.0M | ||
| Q1 25 | — | $104.6M | ||
| Q4 24 | — | $155.2M | ||
| Q3 24 | — | $155.7M | ||
| Q2 24 | $66.9K | $162.2M | ||
| Q1 24 | — | $162.6M |
| Q4 25 | $176.9M | $273.9M | ||
| Q3 25 | $174.9M | $269.9M | ||
| Q2 25 | $172.6M | $263.5M | ||
| Q1 25 | $171.9M | $258.7M | ||
| Q4 24 | $169.8M | $253.0M | ||
| Q3 24 | $168.7M | $253.2M | ||
| Q2 24 | $166.0M | $245.2M | ||
| Q1 24 | $165.8M | $233.7M |
| Q4 25 | $217.2M | $2.2B | ||
| Q3 25 | $218.4M | $2.2B | ||
| Q2 25 | $216.9M | $2.3B | ||
| Q1 25 | $214.9M | $2.3B | ||
| Q4 24 | $208.0M | $2.3B | ||
| Q3 24 | $212.3M | $2.3B | ||
| Q2 24 | $214.2M | $2.4B | ||
| Q1 24 | $209.6M | $2.3B |
| Q4 25 | — | 0.38× | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.40× | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 0.61× | ||
| Q2 24 | 0.00× | 0.66× | ||
| Q1 24 | — | 0.70× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $171.0K | $34.4M |
| Free Cash FlowOCF − Capex | $-227.0K | $33.4M |
| FCF MarginFCF / Revenue | -0.9% | 140.2% |
| Capex IntensityCapex / Revenue | 1.6% | 4.0% |
| Cash ConversionOCF / Net Profit | 0.08× | 6.08× |
| TTM Free Cash FlowTrailing 4 quarters | $5.7M | $54.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $171.0K | $34.4M | ||
| Q3 25 | $1.7M | $14.0M | ||
| Q2 25 | $4.2M | $5.5M | ||
| Q1 25 | $3.1M | $2.2M | ||
| Q4 24 | $2.2M | $93.2M | ||
| Q3 24 | $1.7M | $11.9M | ||
| Q2 24 | $4.6M | $54.9M | ||
| Q1 24 | $2.8M | $-11.9M |
| Q4 25 | $-227.0K | $33.4M | ||
| Q3 25 | $-177.0K | $13.7M | ||
| Q2 25 | $3.6M | $5.2M | ||
| Q1 25 | $2.6M | $2.1M | ||
| Q4 24 | $1.5M | $89.4M | ||
| Q3 24 | $-148.0K | $10.5M | ||
| Q2 24 | $4.2M | $53.8M | ||
| Q1 24 | $2.6M | $-12.8M |
| Q4 25 | -0.9% | 140.2% | ||
| Q3 25 | -0.7% | 57.4% | ||
| Q2 25 | 13.1% | 23.0% | ||
| Q1 25 | 9.4% | 10.0% | ||
| Q4 24 | 6.0% | 394.0% | ||
| Q3 24 | -0.6% | 49.0% | ||
| Q2 24 | 16.1% | 278.6% | ||
| Q1 24 | 10.2% | -71.8% |
| Q4 25 | 1.6% | 4.0% | ||
| Q3 25 | 7.2% | 1.3% | ||
| Q2 25 | 2.4% | 1.0% | ||
| Q1 25 | 2.2% | 0.3% | ||
| Q4 24 | 3.0% | 16.7% | ||
| Q3 24 | 7.2% | 6.7% | ||
| Q2 24 | 1.6% | 5.9% | ||
| Q1 24 | 0.7% | 4.8% |
| Q4 25 | 0.08× | 6.08× | ||
| Q3 25 | 0.75× | 2.02× | ||
| Q2 25 | 5.79× | 0.92× | ||
| Q1 25 | 1.26× | 0.48× | ||
| Q4 24 | 1.14× | 15.23× | ||
| Q3 24 | 0.53× | 2.63× | ||
| Q2 24 | 5.54× | 59.35× | ||
| Q1 24 | 1.50× | -6.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
LCNB
Segment breakdown not available.
